Ten Largest Investments

Summary by AI ^BETAClose X

JPMorgan European Growth & Income PLC has disclosed its ten largest investments as a percentage of total assets as of March 31, 2026. The top holding is Asml at 5.2%, followed by Novartis at 4.0% and Roche Holding AG at 3.6%. Nestle represents 3.0% of the portfolio, with Totalenergies at 2.7%. JPMorgan European Discovery Trust Plc, Banco Santander, and ABB Ltd each account for 2.3%, while Siemens and Unicredit SPA are each at 2.1%. These top ten investments collectively represent 29.6% of the Company's total assets, excluding liquidity stocks.

Disclaimer*

JPMorgan European Grwth & Inc PLC

14 April 2026

JPMORGAN EUROPEAN GROWTH & INCOME PLC (the 'Company')
Legal Entity Identifier: 549300D8SPJFHBDGXS57
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 March 2026
Asml	5.2%
Novartis	4.0%
Roche Holding AG	3.6%
Nestle	3.0%
Totalenergies	2.7%
JPMorgan European Discovery Trust Plc	2.3%
Banco Santander	2.3%
ABB Ltd	2.3%
Siemens	2.1%
Unicredit SPA	2.1%
Total	29.6%
Excludes Investments in Liquidity stocks
Name of contact and telephone number for queries:
Paul Ainger 0044 207 742 6524
Name of authorised company official responsible for making this notification:
Paul Winship 0044 207 742 9815 - Company Secretary
Date: 14 April 2026

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END